Cognitive Performance in Schizophrenia and Bipolar Disorder and Their First-Degree Relatives
CSEF · 2014 Behavioral & Social Sciences
Overview
Objectives/Goals To examine differences in cognitive performance among control, SZ & BD patient groups, & their first-degree relatives, and determine the degree of genetic liability of BD & SZ to their first-degree relatives. Methods/Materials All subjects in this study were recruited from the UCI Neuropsychiatric Center and/or from the local community. An onsite psychiatrist evaluated the SZ & BD patients for their diagnoses to be in this study. Patients and controls were given a series of standard clinical self-reporting scales that evaluate the patient#s symptom severity and type. A computerized neurocognitive test battery, CMINDS (Computerized Multiphasic Interactive Neurocognitive Diagnostics System), was used to assess specific neuropsychological measures in controls and patients with SZ and BD. Results Post-hoc statistical comparisons showed significant differences between groups in the predicted direction. As expected, controls performed better than the patient groups (BD, SAD, SCPT) and their first-degree relatives in all of the cognitive tasks. Newman-Keuls post-hoc comparison and one-way analysis of variance (ANOVA) tests revealed significant differences for individual tests and cognitive domains. SAD performed substantially worse than SCPT, with BD performing the best out of all the patient groups. The degree of cognitive deficits in first-degree relatives and controls was also examined using ANOVA for individual assessments. Controls showed significant differences from first-degree relatives in specific individual assessments. Conclusions/Discussion Differences in cognitive performance among control, SZ & BD patient groups, and their first-degree relatives, are prevalent and can serve as a significant trait marker for genetic liabiliity in first-degree relatives as well as help distinguish between bipolar disorder (BD) and schizophrenia (SZ). First-degree relatives are subject to the cognitive deficits that their affected relatives possess, and thus, an effective method of treatment and diagnosis for both SZ and BD is suggested for future research.
Summary statement
The focus of this study is to determine whether cognitive performance can serve as a trait marker between SZ & BD patients and also, to study the degree of genetic liability in first degree relatives in relation to the patient groups.
Help received
This research was carried out under the guidance of Dr. Julie Patterson at UCI Neuropsychiatric Center, and all research data and software is the property of University of California, Irvine.
Competition history
- CSEF 2014
Resources
Related projects
ISEF · 2014
Cognitive Performance in Schizophrenia & Bipolar Disorder & their First-Degree Relatives
AJAS · 2017
Distinguishing Psychiatric Subtypes: Blink Rate, Sensory Gating, and Symptom Differences
ISEF · 2025
Harmony Plus: A User-Adaptive System for Neurocognitive Rehabilitation With Genetic Personalization and Real-Time Cognitive Load Monitoring in Bipolar Disorder
ISEF · 2022
A Novel Evaluation of Current Psychiatric Treatment Paradigms Involving Polypharmacy via Resting-State Functional Magnetic Resonance Imaging (fMRI) in a Sample of Patients With Bipolar I Disorder
ISEF · 2023
A Logistic Regression Model Representing the Genetic Landscape Differences Between Bipolar Disorder 1 and Bipolar Disorder 2
AJAS · 2019
N100 and P50 Suppression in Schizophrenia and Bipolar Disorder: Effects of Time Block
CSEF · 2016
Using Circadian Rhythm Gene SNPs, Sleep-Wake Phenotypes, and MRI Morphometrics to Diagnose Cognitive Impairment Diseases
JSHS · 2022
A Novel Evaluation of Current Psychiatric Treatment Paradigms Involving Polypharmacy via Resting-State Functional Magnetic Resonance Imaging (fMRI) in a Sample of Patients with Bipolar I Disorder
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects